<DOC>
	<DOCNO>NCT01003431</DOCNO>
	<brief_summary>This study evaluate immunogenicity safety pertussis component DTwP ( whole-cell pertussis contain vaccine ) administer concomitantly RotaTeq™ Rotatrix™ .</brief_summary>
	<brief_title>A Study Immunogenicity Safety Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ ( V260 ) Rotarix™ ( V260-036 ) ( WITHDRAWN )</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant History abdominal disorder , intestinal folding , abdominal surgery Impaired immune system Prior administration rotavirus vaccine DTwP/DTaP Fever &gt; = 38.1C ( 100.5F ) time vaccination History prior rotavirus infection , chronic diarrhea , failure thrive Evidence active gastrointestinal illness</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>